These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2331569)

  • 21. Interaction of the Paf antagonist WEB 2086 and its hetrazepine analogues with human platelets and endothelial cells.
    Korth R; Hirafuji M; Keraly CL; Delautier D; Bidault J; Benveniste J
    Br J Pharmacol; 1989 Oct; 98(2):653-61. PubMed ID: 2555017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of a Paf antagonist, WEB 2086, on airway microvascular leakage in the guinea-pig and platelet aggregation in man.
    Evans TW; Dent G; Rogers DF; Aursudkij B; Chung KF; Barnes PJ
    Br J Pharmacol; 1988 May; 94(1):164-8. PubMed ID: 3401633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet activating factor potentiates rat paw oedema induced by different phlogogen agents.
    Izzo AA; Mascolo N; Di Urno MV; Autore G; Di Carlo G; Capasso F
    Agents Actions; 1994 May; 41(3-4):140-3. PubMed ID: 7524288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition by WEB 2086, a PAG-acether antagonist of oedema and peritonitis induced by zymosan in rats.
    Damas J; Remacle-Volon G; Nguyen TP
    Arch Int Pharmacodyn Ther; 1990; 306():161-9. PubMed ID: 2076045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor.
    Casals-Stenzel J; Muacevic G; Weber KH
    J Pharmacol Exp Ther; 1987 Jun; 241(3):974-81. PubMed ID: 3598913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective effect of propionyl-L-carnitine against PAF-induced rat paw oedema.
    Caruso A; Cutuli VM; De Bernardis E; Leonardi G; Amico-Roxas M
    Pharmacol Res; 1995 Jan; 31(1):67-72. PubMed ID: 7784308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostaglandin receptors EP2, EP3, and IP mediate exudate formation in carrageenin-induced mouse pleurisy.
    Yuhki K; Ueno A; Naraba H; Kojima F; Ushikubi F; Narumiya S; Oh-ishi S
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1218-24. PubMed ID: 15316088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Y-24180, a long-acting antagonist to platelet-activating factor (PAF), on PAF-induced reactions: a relationship between the partial structure of the compound and its duration of the action.
    Kagoshima M; Tomomatsu N; Iwahisa Y; Yamaguchi S; Kawakami Y; Terasawa M
    Pharmacology; 1997 May; 54(5):261-70. PubMed ID: 9380772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist.
    Tsunoda H; Sakuma Y; Harada K; Muramoto K; Katayama S; Horie T; Shimomura N; Clark R; Miyazawa S; Okano K
    Arzneimittelforschung; 1990 Nov; 40(11):1201-5. PubMed ID: 2085331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative study of the effect of CV-6209, a specific PAF-antagonist, on rat paw edema caused by different phlogogen agents.
    Merlos M; Gómez LA; Vericat L; García-Rafanell J; Forn J
    Pharmacology; 1990; 40(4):211-7. PubMed ID: 1697076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of prostaglandin production in the inflammatory tissue by loxoprofen-Na, an anti-inflammatory prodrug.
    Sugimoto M; Kojima T; Asami M; Iizuka Y; Matsuda K
    Biochem Pharmacol; 1991 Nov; 42(12):2363-8. PubMed ID: 1764120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. WEB 2086. A potent PAF antagonist exerts protective effect toward PAF-induced gastric damage.
    Brambilla A; Ghiorzi A; Giachetti A
    Pharmacol Res Commun; 1987 Feb; 19(2):147-51. PubMed ID: 3588650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bronchial and vascular effects of Paf in the rat isolated lung are completely blocked by WEB 2086, a novel specific Paf antagonist.
    Casals-Stenzel J; Franke J; Friedrich T; Lichey J
    Br J Pharmacol; 1987 Aug; 91(4):799-802. PubMed ID: 3664079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of a novel PAF antagonist, E6123, on PAF-induced biological responses.
    Tsunoda H; Sakuma Y; Harada K; Muramoto K; Katayama S; Horie T; Shimomura N; Clark R; Miyazawa S; Okano K
    Agents Actions Suppl; 1990; 31():251-4. PubMed ID: 2080757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of azelastine on platelet-activating factor and antigen-induced pleurisy in rats.
    Lima MC; Martins MA; Perez SA; Silva PM; Cordeiro RS; Vargaftig BB
    Eur J Pharmacol; 1991 May; 197(2-3):201-7. PubMed ID: 1680710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of hetrazepine PAF antagonists in preclinical models of asthma.
    Heuer HO
    Agents Actions Suppl; 1991; 34():229-45. PubMed ID: 1793067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of PAF-antagonists in mouse ear oedema induced by several inflammatory agents.
    Merlos M; Gómez LA; Giral M; Vericat ML; García-Rafanell J; Forn J
    Br J Pharmacol; 1991 Dec; 104(4):990-4. PubMed ID: 1810607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactions between local inflammatory and systemic haematological effects of PAF-acether in the rat.
    Martins MA; Silva PM; Castro HC; Neto F; Lima MC; Cordeiro RS; Vargaftig BB
    Eur J Pharmacol; 1987 Apr; 136(3):353-60. PubMed ID: 3609124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of PAF-induced histamine secretion and bronchoconstriction by WEB 2086.
    Chand N; Pillar J; Nolan K; Diamantis W; Sofia RD
    Res Commun Chem Pathol Pharmacol; 1990 Jan; 67(1):155-8. PubMed ID: 1691522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. WEB 2086, a novel specific PAF antagonist, prevents PAF induced arrhythmogenicity.
    Mest HJ; Riedel A; Rein T
    Pharmacol Res; 1990; 22(4):445-53. PubMed ID: 2402478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.